Atlas Trials

PharmaEngine

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch PharmaEngine

RecordFirmDate
A Study of PEP08 in Patients With MTAP-Del Advanced or Metastatic Solid Tumors (NCT06973863)PharmaEngine2025-08-26
A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients with Advanced or Metastatic Solid Tumors (NCT05983523)PharmaEngine2024-03-27
A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer (NCT05659732)PharmaEngine2023-07-17
Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid Tumors (NCT03810742)PharmaEngine2019-03-05
A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer (NCT02901483)PharmaEngine2016-10-11
A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer (NCT02465593)PharmaEngine2015-06-01
Phase I and Pharmacokinetic Study of Biweekly PEP02 in mCRC Refractory to 1st-line Oxaliplatin Base Therapy (NCT00940758)PharmaEngine2009-06-01
Study of PEP02 as a Second Line Therapy for Metastatic Pancreatic Cancer (NCT00813163)PharmaEngine2009-01-01
Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma (NCT00813072)PharmaEngine2007-11-01
A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Tumors (NCT02884128)PharmaEngine2006-01-01
Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00219648)PharmaEngine2004-09-01

Track PharmaEngine automatically

Every clearance here is in the API, with alerts when new ones post.